Atlas Trials

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Clinical trial NCT02926937 · COMPLETED

Trial details

NCT number
NCT02926937
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-11-11
Primary completion
2019-04-22
Enrollment
399

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.